Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012)
Dexcom (DXCM) reported Non-Current Deffered Revenue of $600000.0 for Q4 2012, up 100.0% year-over-year from $300000.0 in Q1 2012, and up 5.45% quarter-over-quarter from $569000.0 in Q3 2012.
Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012) Analysis & Trends
Dexcom (DXCM) has 2 years of Non-Current Deffered Revenue data on file, last reported at $600000.0 in Q4 2012.
- Non-Current Deffered Revenue for Q4 2012 came in at $600000.0, up 100.0% year-over-year; the trailing twelve-month figure through Dec 2012 was $600000.0 (up 100.0% YoY), and the FY2012 annual result was $600000.0, up 100.0% from the prior year.
- Non-Current Deffered Revenue improved to $600000.0 in Q4 2012 per DXCM's latest filing, from $569000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $834000.0 in Q1 2012 and troughed at $300000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 600,000.00 |
| Sep 30, 2012 | 569,000.00 |
| Jun 30, 2012 | 702,000.00 |
| Mar 31, 2012 | 834,000.00 |
| Dec 31, 2011 | 300,000.00 |